AltruBio

AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.

Health and bio

TIMELINE · MONEY RAISED

AltruBio | 318 days from website to first raise on record

Raised $288M in 2 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

1. May 21, 2024
   Series B+ · $225M
   BBiotechnology Value Fund (lead), AaMoon Fund, BBlackstone, CCormorant Asset Management, DDelos Capital, RRA Capital Management, SSoleus Capital
   Source: fundraisingfox.com
2. April 15, 2021
   Series A · $63M
   AaMoon Fund (lead), BBiotechnology Value Fund, CCAM Capital
   Source: altrubio.com
3. June 1, 2020
   Website created

Team

• JG
  Jeroen Grasman CFO
• SL
  Shih-Yao Lin Vice President

Investors

• AaMoon Fundlead investor
• BBiotechnology Value Fundlead investor
• BBlackstone
• CCAM Capital
• CCormorant Asset Management
• DDelos Capital
• RRA Capital Management
• SSoleus Capital

Companies like AltruBio

• TTriveni$65M Series B+ · Jun 2026
• TTubulis$360M Series B+ · Oct 2025
• AAdcytherixSeries A · Oct 2025
• SSynthekine$100M Series B+ · Jan 2023
• DDren Bio$350M Series B+ · Oct 2026
• AAsher Bio$55M Series B+ · Apr 2024

Other companies backed by Biotechnology Value Fund

• DDren Bio$350M Series B+ · Oct 2026
• CContraline$92.5M Series B+ · Jun 2026
• CCrossbow Therapeutics$77M Series B+ · Mar 2026
• TThird Arc Bio$52M Series A · Feb 2026
• MMerida Biosciences$120M Series A · May 2025
• AAlpha-9 Oncology$175M Series B+ · Oct 2024

Biotechnology Value Fund portfolio →